BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics

Conditions:   Non Small Cell Lung Cancer;   Microbiome;   Metagenome;   Immunotherapy;   Melanoma
Intervention:   Biological: Collection of stool, blood (PBMC) and biopsy (FFPE)
Sponsors:   Ardigen;   National Center for Research and Development, Poland
Recruiting